Interestingly, unlike many other anticancer drugs, and probably because of its lower toxicity in normal cells, BCP seems to work as a dual modulator of oxidative stress, increasing reactive oxygen species (ROS) in cancer cells, and thus enhancing apoptosis, but reducing ROS in normal cells to protect them from damage [4,14]. This evidence concerns the gene OPN1SW and cancer.